|
CN111960048A
|
|
Supporting type conveying line
|
|
CN107362364A
|
|
Endoplasmic reticulum Ca2+Application of the blocking agent in the medicine for preparing treatment body internal organs arsenic poisoning
|
|
CN107714696A
|
|
Endoplasmic reticulum Ca2+Application of the blocking agent in the medicine for preparing treatment cranial nerve arsenic poisoning
|
|
CN107583053A
|
|
Endoplasmic reticulum Ca2+Application of the blocking agent in the medicine for preparing treatment bone arsenic poisoning
|
|
CN105055427A
|
|
Application of chenodeoxycholic acid as active constituent to preparing medicine for treating echinococcosis granulosa
|
|
CN105012344A
|
|
Application of arsenic trioxide in preparation of medicine for treatment of echinococcosis granulosa
|
|
CN105012316A
|
|
Application of cholic acid as active ingredient in preparation of medicine for treatment of echinococcosis granulosa
|
|
CN105012291A
|
|
Application of ERK inhibitor PD98059 in preparation of medicine for treatment of alveolar hydatid disease
|
|
CN104342456A
|
|
Method for transfecting interfering RNA to echinococcus granulosus by virtue of electroporation
|
|
CN104382911A
|
|
Application of tauroursodeoxycholic acid salt used as active ingredient in preparation of drug for treating echinococcosis
|
|
CN102184390A
|
|
Container number-orientated character image identification method
|
